Is there a place for whole abdominal radiotherapy in the management of ovarian cancer?

Annals of the Academy of Medicine Singapore

Volumn 25, Issue 3, 1996, Pages 429-436

  Morton, G C ^a   Thomas, G M ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

adjuvant; consolidation; radiation; survival

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; MELPHALAN; PACLITAXEL;

ABDOMINAL RADIOTHERAPY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; FEMALE; HUMAN; OVARY CANCER; OVARY CARCINOMA; REVIEW;

ABDOMEN; ABDOMINAL NEOPLASMS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; PATIENT SELECTION; PELVIC NEOPLASMS; PELVIS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; RISK FACTORS; SURVIVAL RATE;

EID: 0029837218     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Wingo P A, Tong T, Bolden S Cancer statistics, 1995 CA Cancer J Clin 1995; 45:8-30.
2. Neijt J P, ten Bokkel Huinink W W, van der Burg M E L, van Oosteram A T, Willemse P H B, Vermorken S B, et al Long-term survival in ovarian cancer. Eur J Cancer 1991, 27:1367-72.
3. Hoskins P J, O'Reilly S E, Swenerton E D, Spirelli J J, Fairey R N, Benedet J L. Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy. J Clin Oncol 1992; 10.1561-8
4. Bertelsen K, Andersen J E. Long-term survival and prognostic factors in advanced epithelial ovarian cancer with special emphasis upon the effects of protocol inclusion. Int J Gynecol Cancer 1994, 4:180-7.
5. McGuire W P, Hoskins W J, Brady M F, Kucera P R, Partridge E E, Look K Y, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996, 334.1-6.
6. Ozols R F, Fisher R I, Anderson T, Makuch R, Young R C. Peritoneoscopy in the management of ovarian cancer. Am J Obstet Gynecol 1981; 140:611-9
7. Piver M S, Barlow J J, Lele S B Incidence of subclinical metastasis in stage I and II ovarian carcinoma. Obstet Gynecol 1978; 52:100-4
8. Hacker N F, Berek J S, Lagasse L D, Nieberg R K, Elashoff R M. Primary cytoreductive surgery for epithelial ovarian cancer Obstet Gynecol 1983, 61:413-20.
9. Delgado G, Oram D H, Petrelli E G Stage III epithelial ovarian cancer the role of maximal surgical reduction. Gynecol Oncol 1984; 18:293-8
10. Griffiths C T Surgical resection of tumour bulk in the primary treatment of ovarian cancer. Natl Cancer Inst Monograph 1975; 42:101-4
11. Vogl S E, Pagano M, Kaplan B H, Greenwald E, Arsenau J, Bennett B Cisplatin based combination chemotherapy for advanced ovarian cancer: high overall response rate with curative potential only in women with small tumor burdens. Cancer 1983; 51:2024-30.
12. Neijt J P, van der Burg M E L, Vriesendorp R, van Lindert A C M, van Lert M, ten Bokkel Huinink W W, et al. Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma. Lancet 1984; 2:594-600.
13. Pohl R, Dallenback-Hellweg G, Plugge T, Czernobilsky B. Prognostic parameters in patients with advanced malignant ovarian tumors Eur J Gynecol Oncol 1984, 3.160-9.
14. Redman J R, Petroni G R, Saigo P E, Geller N L, Hakes T B Prognostic factors in advanced ovarian cancer J Clin Oncol 1986; 4:515-23
15. Conte P F, Bruzzone M, Chiara S, Sertoli M R, Dama M G, Rubagotti A, et al. A randomised trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin and cyclophosphamide in advanced ovarian cancer. J Clin Oncol 1986; 4:965-71.
16. Blythe J G, Wahl T P. Debulking surgery: does it increase the quality of survival? Gynecol Oncol 1982; 14:396-408
17. Dembo A J. Abdominopelvic radiotherapy in ovarian cancer, a 10-year experience. Cancer 1985; 55:2285-90.
18. Fuller D B, Sause W T, Plenk H P, Menlove R L. Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma. J Clin Oncol 1987; 5.897-905.
19. Martinez A, Schray M F, Howes A E, Bagshaw M A Postoperative radiation therapy for epithelial ovarian cancer the curative role based on a 24-year experience. J Clin Oncol 1985; 3:901-11
20. Lindner H, Willich H, Atzinger A Primary adjuvant whole abdominal irradiation in ovarian cancer. Int J Radiat Oncol Biol Phys 1990; 19:1203-6
21. Weiser E B, Burke T W, Heller P B, Woodward J, Hoskins W J, Park A C. Determinants of survival of patients with epithelial ovarian carcinoma following whole abdominal radiation (WAR). Gynaecol Oncol 1988; 30:201-8
22. Reinfuss M, Kojs Z, Skolyszewski J. External beam radiotherapy in the management of ovarian carcinoma. Radiother Oncol 1993; 26.26-32.
23. Dembo A J, Davy M, Stenwig A E, Berle E J, Bush R S, Kjorstad K Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1990; 75 263-73
24. Carey M S, Dembo A J, Simm J E, Fyles AW, Treger T, Bush R S. Testing the validity of a prognostic classification in patients with surgically optimal ovarian carcinoma: a 15-year review Int J Gynecol Cancer 1993, 3 24-35.
25. Ledermann J A, Dembo A J, Sturgeon F G, Fine S, Bush R S, Fyles A W, et al. Outcome of patients with unfavourable optimally cytoreduced ovarian cancer treated with chemotherapy and whole abdominal radiation. Gynecol Oncol 1991; 41:30-5.
26. Blais A, Oza A M, Fyles A W, Pintilie M. A retrospective study evaluating the value of abdominopelvic radiotherapy in addition to cisplatin based chemotherapy for high risk, optimally cytoreduced ovarian cancer [Abstract]. Proceedings of the American Society of Clinical Oncology, Thirty-First Annual Meeting, 1995 May 20-23; Los Angeles. Los Angeles, CA: W B Saunders, 1995, 14.286
27. Bush R S, Allt W E C, Beale F A, Bean H, Pringle J F, Sturgeon J. Treatment of epithelial carcinoma of the ovary, operation, irradiation and chemotherapy. Am J Obstet Gynecol 1977; 127:692-704.
28. Dembo A J. Radiotherapeutic management of ovarian cancer. Semin Oncol 1984; 11:238-50.
29. Goldberg N, Peschel R E. Postoperative abdominopelvic radiation therapy for ovarian cancer. Int J Radiat Oncol Biol Phys 1988, 14.425-9.
30. Leers W H, Koch H C The evaluation of postoperative irradiation in patients with early-stage ovarian cancer Gynecol Oncol 1987; 28:41-9.
31. van Bunningen B, Bouma J, Kooijman C, Warlam-Rodenhuis C C, Heintz A P, van Lindert A. Total abdominal irradiation in stage I and II carcinoma of the ovary Radiother Oncol 1988; 11:305-10.
32. Macbeth F R, MacDonald H, Williams C J. Total abdominal and pelvic radiotherapy in the management of early stage ovarian carcinoma. Int J Radiat Oncol Biol Phys 1988, 15 353-8.
33. Fletcher G H Clinical dose-response curves of human malignant epithelial tumours. Br J Radiol 1973; 46:1-12
34. Withers H R, Peters L J, Taylor J M G Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys 1995; 31:353-9.
35. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider J E, et al. Tolerance of normal tissue to therapeutic radiation. Int J Radiat Oncol Biol Phys 1991; 21:109-22.
36. Dembo A J, Bush R S Choice of postoperative therapy based on prognostic factors. Int J Radiat Oncol Biol Phys 1982; 8:893-7.
37. Schray M F, Martinez A, Howes A E. Toxicity of open field whole abdominal irradiation as primary post-operative treatment in gynecological malignancy. Int J Radiat Oncol Biol Phys 1988, 16:397-403.
38. Dembo A J, Bush R S, Beale F A, Bean H A, Brown T C, Fine S, et al. A randomised clinical trial of moving strip versus open field whole abdominal irradiation in patients with invasive epithelial cancer of ovary [abstract] Int J Radiat Oncol Biol Phys 1983; 9(suppl):97.
39. Fyles A W, Dembo A J, Bush R S, Levin W, Manchul L A, Pringle J F, et al. Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma. Int J Radiat Oncol Biol Phys 1992; 22 847-51.
40. Dembo A J. Epithelial ovarian cancer: the role of radiotherapy. Int J Radiat Oncol Biol Phys 1992; 22:835-45.
41. Chiara S, Conte P, Franzone P, Orsatti M, Bruzzone M, Rubagotti A, et al. High-risk early-stage ovarian cancer. Randomised clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy. Am J Clin Oncol (CCT) 1994; 17:72-6.
42. Redman C W E, Mould J, Warwick J, Rollason T, Luesley D M, Budder J, et al. The West Midlands epithelial ovarian cancer adjuvant therapy trial Clin Oncol 1993, 5:1-5.
43. Klaassen D, Shelley W, Starreveld A, Kirk M, Boyes D, Gerulath A, et al. Early stage ovarian cancer: a randomised clinical trial comparing whole abdominal radiotherapy, Melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report. J Clin Oncol 1988, 6:1254-68
44. Sell A, Bertelsen K, Andersen J E, Stroyer I, Pandoro J. Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. Gynecol Oncol 1990; 37:367-73.
45. Hoskins P J, Swenerton K D, Manji M, Wong F, O'Reilly S E, McMurtrie E J, et al. "Moderate Risk" ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelviabdominal irradiation Int J Gynecol Cancer 1994; 4:272-8.
46. Ozols R F, Young R C. Chemotherapy of ovarian cancer. Semin Oncol 1991; 18:222-32.
47. Rubin S C, Hoskins W J, Hakes T B, Markman M, Cain J M, Lewis J L Jr. Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors. Am J Obstet Gynecol 1988; 159:1094-8.
48. Desjardins C, Pater J, Zee B, Torri W, Marsoni S, Colombo N, et al. Prognostic factors after a negative second-look laparotomy in ovarian cancer: a Canadian-Italian study [abstract] Ann Oncol 1992; 3(suppl 5):107.
49. Louie K G, Behrens B C, Kinsella T J, Hamilton T C, Grotzinger K R, McCoy W M, et al. Radiation survival parameters of antineoplastic drug-sensitive and resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Cancer Res 1985; 45:2110-5.
50. De Pooter C M, Scalliet P G, Elst H J, Huybrechts J J, Ghevers E E O, van Oosterom A T, et al. Resistance patterns between cisdiammine-dichloroplatinum (CDDP) and ionising radiation. Cancer Res 1991; 51:4523-7.
51. Thomas G M. Is there a role for consolidation or salvage radiotherapy after chemotherapy m advanced epithelial ovarian cancer. Gynecol Oncol 1993; 51:97-103.
52. Chiara S, Orsatti M. Franzone P, Scarpati D, Bruzzone M, Repetto L, et al. Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer. Clin Oncol 1991, 3.340-4.
53. Greiner R, Goldhirsch A, Davis B W, Dreher E, Peyer T, Locher G, et al. Whole-abdomen radiation in patients with advanced ovarian carcinoma after surgery, chemotherapy and second-look laparotomy. J Cancer Res Clin Oncol 1984; 107.94-8.
54. Reddy S, Hartsell W, Graham I, Yordan E L, Lee M S, Sarin P, et al Whole-abdomen radiation therapy in ovarian carcinoma: Its role as a salvage therapeutic modality. Gynecol Oncol 1989; 35:307-13.
55. Kuten A, Stein M, Steiner M, Rubinov R, Epelbaum R, Cohen Y Whole abdominal irradiation following chemotherapy in advanced ovarian carcinoma. Int J Radiat Oncol Biol Phys 1988; 14:273-9.
56. Solomon H J, Atkinson K H, Coppleson J V M, Elliott P M, Houghton C R S, Murray J, et al. Ovarian carcinoma: Abdominopelvic irradiation following reexploration. Gynecol Oncol 1988; 31:396-401.
57. Kong J S, Peters L J, Whartin J T, Ang K K, Delclos L, Gershenson D M, et al. Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: Tolerance and toxicity. Int J Radiat Oncol Biol Phys 1988; 14 737-43.
58. Rosen E M, Goldberg I D, Rose C, Come S, Goldstein M, Simon L, et al Sequential multi-agent chemotherapy and whole abdominal irradiation for stage III ovarian carcinoma. Radiother Oncol 1986; 7:223-32.
59. Haie C, Pejovic-Lenfant M H, George M, Michel G, Gerbaulet A, Prade M, et al. Whole abdominal irradiation following chemotherapy in patients with minimal residual disease after second look surgery in ovarian carcinoma. Int J Radiat Oncol Biol Phys 1989; 17:15-9.
60. Kersh C R, Randall M E, Constable W C, Hahn S S, Taylor P T, Krebs H B, et al. Whole abdominal radiotherapy following cytoreductive surgery and chemotherapy in ovarian carcinoma. Gynecol Oncol 1988; 31:113-20.
61. Goldhirsch A, Greiner R, Dreher E, Sessa C, Krauer F, Forni M, et al. Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapy. Cancer 1988; 62.40-7
62. Menczer J, Modan M, Brenner J, Ben-Baruch G, Brenner H. Abdominopelvic irradiation for Stage II-IV ovarian carcinoma patients with limited or no residual disease at second-look laparotomy after completion of cisplatinum-based combination chemotherapy Gynecol Oncol 1986; 24:149-54.
63. Morgan L, Chafe W, Mendenhall W, Marcus R. Hyperfractionation of whole-abdomen radiation therapy: Salvage treatment of persistent ovarian carcinoma following chemotherapy. Gynecol Oncol 1988; 31:122-34.
64. Schray M F, Martinez A, Howes A E, Podratz K C, Ballon S C, Malkasian G D Jr, et al. Advanced epithelial ovarian cancer salvage whole abdominal irradiation for patients with recurrent or persistent disease after combination chemotherapy. J Clin Oncol 1988; 6:1433-9.
65. Whelan T J, Dembo A J, Bush R S, Sturgeon J F, Fine S, Pringle J F, et al Complications of whole abdominal and pelvic radiotherapy following chemotherapy for advanced ovarian cancer. Int J Radiat Oncol Biol Phys 1992; 22:853-8.
66. Bruzzone M, Repetto L, Chiara S, Campora E, Conte P F, Orsatti M, et al. Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look. Gynecol Oncol 1990, 38:392-5.
67. Lambert H E, Rustin G J S, Gregory W M, Nelstrop A E. A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study. J Clin Oncol 1993; 11 440-8.
68. Lawton F, Luesley D, Blackledge G, Hilton C, Kelly K, Latief T, et al A randomized trial comparing whole abdominal radiotherapy with chemotherapy following cisplatinum cytoreduction in epithelial ovarian cancer West Midlands Ovarian Cancer Group trial II. Clin Oncol 1990, 2:4-9.